Company intelligence / Profile preview

CR Medicon

China

Ownership: Private
Development stage: Other

Overview

CR Medicon is a full-service clinical CRO, focusing on regulatory affairs, medical affairs, clinical operations, data management, biostatistics, pharmacovigilance, and bioanalysis to support global drug and device development. It was acquired by Pharmaron to enhance their integrated drug development service platform.

Modalities: DeviceSmall moleculeBiologic
Industry: Contract Research Organization

Partnerships

Pharmaron Group (acquirer and integration partner)

Beyond the preview

Go deeper on CR Medicon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CR Medicon.

Explore the full profile